Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters changes component ratings again

Reuters changes component ratings again

posted on Sep 29, 2008 10:11AM

Reuters has a rating system that uses 4 components to calculate a weighted "Overall Investment rating" for companies they watch.

PTSC’s overall rating remains the highest they have = Outperform. "Outperform" designates the companies that rank in the top 30% of companies covered by Reuters

What is somewhat troubling is that within the past few months the 4 components have changed from all being rated Outperform to only 2 being rated Outperform.

The 4 component’s ratings and their % weighting factor are:

Fundamental Quality = Outperform 36%

Technical Factors = Underperform 27% (lowest rating)

Operational Trends = Neutral 13%

Value Catch-up = Outperform 24%

Not surprising, Technical Factors = SP trend,

and Operational Factors = Sales & EPS growth.

If you have access to Reuters reports the detailed analysis is worth looking at – it’s the kind of details large institutional investors watch. It's not a bad story.

Share
New Message
Please login to post a reply